SCHDEULE 13G

Company

Sunshine Biopharma Inc.

Filed

November 2, 2022

Accession Number

0001683168-22-007203

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →